Ouro Medicines, a biotechnology company developing immune reset therapeutics for people living with chronic, immune-mediated ...
Living with an autoimmune disease often means navigating a lifelong, complex condition. A recent study estimates that autoimmune diseases affect 400 to 600 million people worldwide, with the burden ...
MedPage Today on MSN
Double-Action Lupus Drug Looks Good in Phase III Trial
A novel drug for systemic lupus erythematosus (SLE) first developed in China, and approved there since 2021, did well enough in a new placebo-controlled phase III trial that approval in Western ...
Tragic RSV vaccine trials in the 1960s set the field back for decades. Here’s how scientists finally made breakthroughs in RSV immunization ...
Windsor’s plasma donation clinic will soon also be open for blood donations, Canadian Blood Services (CBS) says, more than ...
Researchers at The University of Osaka have discovered precursor T follicular regulatory cells (preTfr), comprising 30-50% of ...
SHANGHAI, NANJING, China and PLEASANTON, Calif., Oct. 16, 2025 /PRNewswire/ -- IASO Biotherapeutics (IASO Bio), a ...
The authors describe an interesting approach to studying the dynamics and function of membrane proteins in different lipid environments. The important findings have theoretical and practical ...
Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback